About Lung Cancer Surgery
Lung cancer surgery is done for the patients in which cancer is caused by formation of tumor owing to uncontrolled growth of cells in the lungs tissues. Primary lung cancer is also known as carcinomas which occurs in the lungs whereas secondary lung cancer begins in other parts of the body. Rising incidences and prevalence of lung cancer demand an innovative and cost effective solution at large scale which provide immense growth opportunity for key players as well as for new entrants.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
CAGR | 7.1% |
The market of solutions for Lung Cancer Surgery is expected to grow with rising demand for surgeries. Numerous companies are operating in the market to provide Lung Cancer Surgery for treatment of lung diseases. The market is highly fragmented with the presence of several market players. They are gaining attention owing to their innovative and novel portfolio. In addition, market profitability is attracting new entrant which is turn impacted on competitive rivalry. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Lung Cancer Surgery market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Accuray Incorporated [United States], Angiodynamics Inc. [United States], Ethicon Us [United States], Johnson & Johnson LLC [Russia], Intuitive Surgical Inc. [United States], Olympus Corporation [Japan], Teleflex Incorporated [United States], Ackermann Instrumente GmbH [Germany], Karl Storz GmbH [Germany], Scanlan International [United States] and Trokamed GmbH [Germany] are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Richard Wolf GmbH [Germany], Neomend Inc [United States], Siemens Healthineers [Germany], Biotronik [Germany], MicroPort Scientific [China] and Abbott Laboratories [United States].
Segmentation Overview
AMA Research has segmented the market of Global Lung Cancer Surgery market by Type (Thoracotomy and Minimally Invasive Surgeries), Application (Hospital, Operating room, Outpatient clinic and Outpatient clinic) and Region.
On the basis of geography, the market of Lung Cancer Surgery has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Influencing Trend:
Growing Research and Developments to Find Cost Effective Solution and Increasing Health Budget in Developing Countries
Market Growth Drivers:
Growing Geriatric Population, Rising Number of Lung Cancer Cases and Technical Advancement Lung Cancer Treatment Methods
Challenges:
Lack of Qualified Oncologist and Lack of Awareness About Advance Surgery Methods In Emerging Countries
Restraints:
High Cost of Lung Cancer Surgeries and Effective Alternative Treatment Methods
Opportunities:
Government Initiatives to Prevent and Treat Cancer and Growing Health Awareness and Disposable Income in Emerging Countries
Market Leaders and their expansionary development strategies
In February 2020, Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery has acquired privately held Orpheus Medical to deepen and expand its integrated informatics platform. With this acquisition, company has strengthen and expanded its existence portfolio.
United States' Food and Drug Administration approved Opdivo (nivolumab) for patients with metastatic small cell lung cancer (SCLC). This is the first immunotherapy treatment approved for SCLC and early approval was the result of positive results of a recent study.
Key Target Audience
Manufacturers of Surgical Robots and Lasers, Vendors and Distributors of Powered Surgical Instruments, Hospitals, Research Institutes Related to Cancer Studies, Venture Capitalists and Investors and Potential Investors
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.